Call for a free consultation | Hablamos español

Prescription & Over-The-Counter Drug Lawsuits

Woman with heartburn.

Recent testing has shown that Zantac may be contaminated with unsafe levels of the cancer-causing chemical NDMA. Some scientific evidence suggests that the ranitidine molecules in Zantac may decompose into NDMA while in storage or inside the human body after ingestion.

Read More

Proton pump inhibitors and heartburn.

There are heartburn drugs—both over-the-counter and prescription—associated with an increased risk of dangerous, sometimes life-threatening, kidney problems.  They include well-known brand names such as Prevacid®, Nexium®, and Prilosec®

Read More

Valsartan high blood pressure medication and potential cancer risks.

Testing has shown that generic valsartan manufactured in recent years may be contaminated with two dangerous, cancer-causing chemicals (NDMA or NDEA) due to changes in the manufacturing process.

Read More

zostavax shingles vaccination

In late 2014, the manufacturer admitted Zostavax could cause shingles, and added that warning to its label. Patients who have contracted shingles or experienced other serious side effects after receiving Zostavax have filed suit seeking compensation

Read More

Belviq lawsuit

The FDA approved the weight-loss drug Belviq (lorcaserin) for sale in 2012. FDA analysis of the data collected in a five-year post-marketing study found a higher incidence of cancer in participants who took Belviq than those in the control group.

Read More

Close up of a female eye.

Elmiron has been widely prescribed for decades to treat interstitial cystitis, a bladder condition that causes chronic pain in the bladder and pelvis area. However, evidence now suggests that prolonged use of Elmiron may be associated with damage to the eyes—specifically to the macula, which is part of the retina.

Read More

Xeljanz lawsuit information

Xeljanz and Xeljanz XR may be prescribed to treat rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis. People who take Xeljanz may be at increased risk for developing cancer or a pulmonary embolism (PE) or deep vein thrombosis (DVT) or experiencing a major cardiac event.

Read More

 Consult your doctor before stopping any prescribed medication.
  >  Drugs